The lysine acetyltransferase (KAT) p300 is a transcription co-regulator, implicated in the pathogenesis of various disease processes including cardiac hypertrophy and fibrosis [10,22,30,44,53-55]. Here, EP300 is linked to cardiac hypertrophy.